Institute for Integrative Therapies

02/12/2026

IIT is happy to announce that our trial site is seeking participants for this clinical trial.

The Elumina study is researching an investigational medicine that may offer a short- term treatment plan to improve depression symptoms.

If you're interested in this trial or any other clinical trial at IIT, reach out to see if you're eligible!

02/10/2026

IIT has been selected as a clinical-trial site for atai Beckley’s VLS-01-203 study—the first DMT study in Minnesota for people living with treatment-resistant depression.

VLS-01 is a novel buccal-film form of DMT, and represents a significant step forward in evidence-based psychedelic medicines for those suffering with TRD that haven't responded to the conventional treatments.

Being part of this landmark trial strengthens IIT’s role as a Midwest leader in psychedelic-medicine research—and, most important, gives Minnesotans early access to tomorrow’s breakthroughs.

11/20/2025

Proud to share that IIT has been selected as a clinical trial site for Cybin’s EMBRACE and EXTEND psilocin studies.

The Institute for Integrative Therapies (IIT), Minnesota’s leading psychedelic medicine clinic, is proud to announce its official selection as a clinical trial

09/16/2025

We are seeking a dedicated and detail-oriented Clinical Research Coordinator (CRC) to support the ex*****on of a psychedelic medicine clinical trial.

Apply now! Details on how to apply are on our website 👉

We are seeking a dedicated and detail-oriented Clinical Research Coordinator (CRC) to support the ex*****on of a psychedelic medicine clinical trial. The CRC will play a key role in ensuring study operations adhere to Good Clinical Practice (GCP), regulatory requirements, and protocol guidelines. Th...

07/25/2025

IIT has officially launched its participation in the global Phase 3 COMPASS Pathways clinical trial studying psilocybin therapy for treatment-resistant depression. We’re honored to be one of a select group of sites in the world contributing to this historic research.

This trial represents the most advanced clinical investigation of psilocybin for depression to date and has the potential to reshape how we treat severe mental illness. It’s also a major milestone for IIT, which began as a ketamine-assisted psychotherapy clinic and has now expanded into a full-scale psychedelic medicine research company.

IIT launches psilocybin depression trial as part of COMPASS Pathways’ global Phase 3 study on treatment-resistant depression.

04/25/2025

Ketamine is a catalyst for change. Move beyond symptom management and start living better. Our infusion program is physician-guided, helping you to understand your unique story and unlock deeper healing. We're here to support your journey.

12/24/2024

Join Our Innovative Integrative Specialty Clinic! The licensed Therapist position is open!

Gain experience in working as a psilocybin facilitator and with psychedelic therapies in a clinical trial.

We are seeking a compassionate and dedicated Therapist to join our team. The ideal candidate will have a strong commitment to high-quality patient care and experience in various therapeutic modalities.

11/15/2024

We’re expanding our access to care at The Institute for Integrative Therapies!

We now accept Cigna and Aetna insurance as part of our commitment to bringing affordable treatments to the larger community.

The Institute for Integrative Therapies is dedicated to the advancement of psychedelics in the field

10/25/2024

We are proud to host our first Ketamine-Assisted Therapy Group Day-long Retreat. This retreat provides attendees the experience of Ketamine-Assisted Psychotherapy with the benefit of community support and expert guidance.

Retreat date: December 14th in Saint Paul, MN

Join us for an experiential journey of personal growth and self-exploration.

08/19/2024

We're seeking a compassionate and dedicated Psychiatric Nurse Practitioner to join the IIT team. Work alongside passionate and experienced healthcare professionals who are leading the way in integrative therapies. Apply today!

07/23/2024

Our Longevity Medicine is featured in Eden Prairie Lifestyle! Check out the article and how we can help extend your health span.

06/06/2024

Jon Tevin recounts his powerful experience with ketamine therapy and healing at IIT. Jon struggled to fight his depression following the death of his wife Ellen. After traditional antidepressants and therapy had failed, Jon was looking for a new path forward.

Ketamine therapy helped to lessen the pain Jon was feeling and shift his perspective around his wife’s death.

We are thankful to Jon for sharing his experience of ketamine therapy with IIT and for destigmatizing the treatment. You can find this article in the StarTribune.